Intratumoral application of the conjugate into mice bearing PSMA expressing PC-3 tumors resulted in a >50% average reduction in tumor size after two weeks and a >90% reduction in PSA levels in animals with LNCaP xenografts [59]. Here, FOLH1 is linked to neoplasm.